Rapid Micro Biosystems, Inc. (RPID)
- Previous Close
0.8200 - Open
0.8450 - Bid --
- Ask --
- Day's Range
0.8300 - 0.8450 - 52 Week Range
0.7400 - 1.1900 - Volume
31,933 - Avg. Volume
45,253 - Market Cap (intraday)
35.58M - Beta (5Y Monthly) 1.18
- PE Ratio (TTM)
-- - EPS (TTM)
-1.2100 - Earnings Date May 3, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
4.75
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts.
www.rapidmicrobio.comRecent News: RPID
Performance Overview: RPID
Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RPID
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RPID
Valuation Measures
Market Cap
35.58M
Enterprise Value
-36.89M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.55
Price/Book (mrq)
0.34
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-224.73%
Return on Assets (ttm)
-23.24%
Return on Equity (ttm)
-40.17%
Revenue (ttm)
23.09M
Net Income Avi to Common (ttm)
-51.9M
Diluted EPS (ttm)
-1.2100
Balance Sheet and Cash Flow
Total Cash (mrq)
79.54M
Total Debt/Equity (mrq)
6.67%
Levered Free Cash Flow (ttm)
--
Research Analysis: RPID
Company Insights: RPID
RPID does not have Company Insights